Accepted for Publication: March 5, 2022.
Published Online: March 18, 2022. doi:10.1001/jama.2022.4308
Corresponding Author: Aaron M. White, PhD, Office of the Director, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, 6700B Rockledge Dr, Bethesda, MD 20852 (email@example.com).
Author Contributions: Dr White had full access to all of the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis.
Concept and design: All authors.
Acquisition, analysis, or interpretation of data: White, Castle, Hingson, Koob.
Drafting of the manuscript: White, Castle, Hingson, Koob.
Critical revision of the manuscript for important intellectual content: All authors.
Statistical analysis: Castle, Hingson.
Administrative, technical, or material support: White, Koob.
Supervision: White, Hingson, Koob.
Conflict of Interest Disclosures: Dr Powell reported Pfizer stock ownership outside the submitted work. No other disclosures were reported.
Disclaimer: The views and opinions expressed in this report are those of the authors and should not be construed to represent the views of the federal government.
Additional Information: All data used in the project are publicly accessible from the website for the Centers for Disease Control and Prevention National Center for Health Statistics.
AM , Curtis
B , Mandrekar
P , Singal
AK , Verna
EC , Fix
OK . Alcohol-associated liver disease before and after COVID-19-an overview and call for ongoing investigation. Hepatol Commun
. 2021;5(9):1616-1621. doi:10.1002/hep4.1747PubMedGoogle ScholarCrossref
AM , Castle
IP , Hingson
RW , Powell
PA . Using death certificates to explore changes in alcohol-related mortality in the United States, 1999 to 2017. Alcohol Clin Exp Res
. 2020;44(1):178-187. doi:10.1111/acer.14239PubMedGoogle ScholarCrossref
IJ , Yi
HY , Hingson
RW , White
AM . State variation in underreporting of alcohol involvement on death certificates: motor vehicle traffic crash fatalities as an example. J Stud Alcohol Drugs
. 2014;75(2):299-312. doi:10.15288/jsad.2014.75.299PubMedGoogle ScholarCrossref